A National Registry For Patients With Hidradenitis Suppurativa

Status Completed

Clinical Trial Summary

Clinical Trial Description

The goal of this study is to get a better understanding of the skin condition, Hidradenitis Suppurativa, and to find out how the disease affects quality of life. The investigators will utilize a compilation of validated questionnaires including the Beck Depression Inventory form, Dermatology Life Quality Index (DLQI), Skindex, SF-36 health survey, the Quality of Life Enjoyment and Satisfaction Questionnaire- short form (Q-LES-Q-SF) and the Employment/Productivity Health Economic Questionnaire as well as other relevant clinical data. The investigators will additionally collect a modified Hidradenitis Suppurativa Lesion, Area, and Severity Index (HS-LASI) (or other appropriate disease severity score as determined by the team) from the physician of each enrollee. The investigators hope this information will help improve treatment for this skin condition. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03289585
Study type	Observational
Source	Montefiore Medical Center
Contact
Status	Completed
Phase
Start date	August 2015
Completion date	September 6, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02904902` - Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa	Phase 3
Completed	`NCT03628924` - A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)	Phase 2
Not yet recruiting	`NCT05531747` - Replicative Stress in Hair Follicle Stem Cells and Pathogeny of Hidradenitis Suppurativa	N/A
Recruiting	`NCT06028230` - A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa	Phase 2
Completed	`NCT03275870` - Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa	Phase 1/Phase 2
Completed	`NCT03248531` - A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.	Phase 2
Withdrawn	`NCT04100083` - Spironolactone for Hidradenitis Suppurativa	Phase 4
Completed	`NCT00329823` - Etanercept in Hidradenitis Suppurativa	Phase 2
Recruiting	`NCT05710393` - Hidradenitis - an Analysis of Genetic Traits and Linkages in Families
Completed	`NCT04019041` - A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa	Phase 2
Completed	`NCT05286567` - A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.	Phase 1
Withdrawn	`NCT03929835` - Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa	Phase 2
Terminated	`NCT04325607` - Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa	N/A
Terminated	`NCT03238469` - Microwave Ablation in Mild Axillary Hidradenitis Suppurativa	N/A
Completed	`NCT04449354` - HidraWear AX HS Study	N/A
Recruiting	`NCT06123429` - Mindfulness in Hidradenitis Suppurativa	N/A
Recruiting	`NCT05934825` - Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa	Phase 1/Phase 2
Recruiting	`NCT05635266` - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting	`NCT06046729` - A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa	Phase 2
Recruiting	`NCT04246372` - Tofacitinib for Immune Skin Conditions in Down Syndrome	Phase 2